Leading the Way in Life Science Technologies

GEN Exclusives

More »
Systems Biology - Related Content
  • Insight & Intelligence™
  • More »
  • A SYSTEMS BIOLOGY VIEW OF CANCER
    - Interview with Reinhard Laubenbacher, Ph.D., Professor, Virginia Bioinformatics Institute, Professor, Department of Mathematics, Virginia Tech, and Adjunct Professor, Department of Cancer Biology, Wake Forest University
  • miRNA BIOMARKERS FOR DRUG-INDUCED LIVER INJURY
    - Interview with David Galas, Ph.D., Senior Vice President of Strategic Partnerships, Institute for Systems Biology

Be sure to take the GEN Poll

Scientifically Studying Ecstasy

MDMA (commonly known as the empathogen “ecstasy”) is classified as a Schedule 1 drug, which is reserved for compounds with no accepted medical use and a high abuse potential. Two researchers from Stanford, however, call for a rigorous scientific exploration of MDMA's effects to identify precisely how the drug works, the data from which could be used to develop therapeutic compounds.

Do you agree that ecstasy should be studied for its potential therapeutic benefits?

More »